Business
Press Release Mar 18 2025
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 18, 2025, titled "Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 18, 2025, titled \"Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg\". View Attachment","length":325,"tagName":"div"}]